by Jordana Choucair | Feb 9, 2023 | M&A
Abbott Laboratories has agreed to acquire Cardiovascular Systems Inc. (CSI) in a deal with a total equity value of about $890 million. In a statement, Abbott officials said the deal would strengthen its portfolio of devices treating vascular disease. The companies...
by Jordana Choucair | Feb 7, 2023 | M&A
CVS Health is closing in on a deal to acquire Medicare-focused primary care company Oak Street Health for about $10.5 billion including debt. Per the Wall Street Journal, if the companies agree to the terms, the deal could be announced as soon as this week. Oak Street...
by Jordana Choucair | Jan 26, 2023 | M&A
Walgreens Boots Alliance Inc. is considering a sale of its pharmacy automation business, which could be valued at as much as $2 billion. According to people familiar with the matter, the company has engaged advisors for the sales process, which could start next month...
by Jordana Choucair | Jan 24, 2023 | M&A
Elevance Health announced plans to acquire Blue Cross and Blue Shield for an undisclosed price. The acquisition builds on an existing partnership between the two insurers – the two jointly own Healthy Blue, a plan that serves Medicaid and dual-eligible beneficiaries....
by Jordana Choucair | Jan 13, 2023 | M&A
Kaufman Hall released its 2022 year-end report, showing that there were 17 hospital merger and acquisition deals announced during the fourth quarter of 2022. Of those, four are set to merge two billion-dollar organizations. In total, 53 deals were announced in 2022,...
by Jordana Choucair | Jan 10, 2023 | M&A
CVS Health Corp. is in talks to buy primary care operator Oak Street Health Inc. for more than $10 billion, including debt. Sources say that deal could be reached in the coming weeks, though they noted that the discussions could end without a deal. (Articles here and...
Recent Comments